Diabetes Intervention Trial With Vitamin D in Subjects of Nordic and Sub-Indian Ethnicity
Status:
Unknown status
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The aim of this 6 months study is to evaluate the metabolic effects of 400.000-600.000 IU of
vitamin D supplementation in subjects with type 2 diabetes and hypovitaminosis D. The main
hypothesis is that subjects with low levels of 25-OH-vitamin D will benefit from
supplementation with cholecalciferol in sufficient doses to optimize serum levels.
Phase:
Phase 2
Details
Lead Sponsor:
University Hospital, Aker
Collaborator:
University of Oslo
Treatments:
Cholecalciferol Ergocalciferols Insulin Vitamin D Vitamins